Columbia University Fertility Center: A Complete Patient Guide

4.3 stars · 5 Columbus Circle, New York, NY · columbiadoctors.org

When Newsweek ranked Columbia University Fertility Center the #1 fertility clinic in the United States for 2025, it was validating what reproductive medicine specialists in New York had known for years: this is not simply a well-run clinic, but a research engine embedded inside one of the world's great medical universities. Operated under the umbrella of NewYork-Presbyterian and Columbia University Irving Medical Center, the fertility center combines the clinical resources of a major academic hospital with a laboratory infrastructure built around scientific advancement rather than throughput alone. For patients navigating infertility in New York City, that distinction matters — and so do the honest trade-offs that come with choosing an institution of this scale. This guide covers everything prospective patients should know before booking a consultation.

Physicians and Clinical Team

The Columbia fertility division is staffed by a group of reproductive endocrinologists who hold dual roles as clinicians and active researchers — a combination that is rare even among academic centers.

Eric J. Forman, MD, HCLD, serves as Medical and Laboratory Director, overseeing both the clinical practice and the IVF embryology and andrology laboratories. The HCLD credential (High Complexity Laboratory Director) is significant: it means Dr. Forman carries direct scientific accountability for the lab that handles your eggs, sperm, and embryos. He has published more than 50 peer-reviewed articles on assisted reproductive technology, with landmark work demonstrating that transferring a single chromosomally normal embryo can achieve live birth rates equivalent to transferring two untested embryos — a finding that has shaped elective single-embryo transfer (eSET) practice nationwide.

Briana J. Rudick, MD directs Columbia's Third Party Reproduction Program, leading all aspects of egg donation, gestational surrogacy, co-maternity arrangements, and fertility care for same-sex couples. Her clinical focus brings specific expertise to patients whose family-building paths involve a third party, a population that benefits from a physician with dedicated program-level experience rather than a generalist approach.

Paula C. Brady, MD is Director of the Oncofertility Program, specializing in fertility preservation for patients facing cancer diagnoses. Her program coordinates care between oncology and reproductive medicine so that patients can bank eggs or embryos before chemotherapy or radiation begins — often within days of a cancer diagnosis, in urgent cases.

Sinem Karipcin, MD founded and directs Columbia's Pre-Pregnancy Genetics Program, which oversees preimplantation genetic testing (PGT). Patients with heritable conditions, recurrent pregnancy loss due to chromosomal factors, or advanced maternal age benefit from working with a physician who helped build the PGT infrastructure rather than simply ordering the test.

Lauren A. Bishop, MD rounds out the Columbus Circle team, adding capacity for IVF, IUI, and general reproductive endocrinology care. The department's faculty also participate in training Columbia's own OB/GYN residents and REI fellows, which means physician expertise is continuously renewed and vetted by peers. Visit the Columbia University Fertility Center website for the most current provider roster.

Services and Treatments

Columbia's service line covers the full spectrum of reproductive medicine:

• In Vitro Fertilization (IVF) — fresh and frozen embryo transfer cycles using the center's in-house embryology lab
• Intrauterine Insemination (IUI) — for appropriate candidates, including same-sex female couples using donor sperm
• Egg Freezing and Embryo Banking — elective social freezing and medically indicated fertility preservation using vitrification technology, which Columbia's research confirmed does not elevate the risk of chromosomal abnormalities in resulting embryos
• Preimplantation Genetic Testing (PGT-A and PGT-M) — chromosomal screening and single-gene disorder testing prior to transfer
• Oncofertility — urgent and planned fertility preservation for patients with cancer diagnoses
• Donor Egg IVF — with rigorous clinical screening of donors
• Gestational Surrogacy and Egg Donation — coordinated through the dedicated Third Party Reproduction Program
• Male Factor Evaluation and Treatment — including andrology lab services
• LGBTQ+ Family Building — inclusive care for same-sex couples, single parents by choice, and gender-diverse patients

Two practice locations serve patients: the flagship at 5 Columbus Circle, Suite PH (midtown Manhattan), and a Westchester location at 244 Westchester Avenue, White Plains — giving New York City residents and suburban patients access without requiring travel between boroughs.

Research and Academic Distinction

Columbia's fertility program is distinguished not just by rankings but by the research infrastructure that underpins clinical practice. The center is one of only a handful of fertility programs in the United States to have received the SART Platinum Award — SART's highest designation for outstanding outcomes and complete reporting — for two consecutive years. That award reflects not only strong live birth rates but also the transparency and data integrity that academic medical centers are held to at a higher standard than private clinics.

Dr. Forman's randomized controlled trial on elective single-embryo transfer, published in peer-reviewed journals, directly influenced clinical guidelines on reducing multiple gestations in IVF. Dr. Karipcin's Pre-Pregnancy Genetics Program positions Columbia at the intersection of IVF and genomic medicine — an area that is evolving rapidly and where access to a program that helped develop the protocols carries real clinical value. The center also leverages the broader Columbia University Irving Medical Center ecosystem: molecular biologists, reproductive immunologists, and genetic counselors who are available as consultants in complex cases.

For patients, the research-active environment has practical consequences. Protocols are updated as evidence evolves. Physicians see the latest clinical data before it becomes mainstream. Rare or complex conditions — recurrent implantation failure, unexplained infertility after multiple failed cycles, severe male factor — are more likely to trigger a multi-disciplinary workup than a repeat of the same protocol.

Columbia's SART 2023 data reflects this capability: 4,517 total cycles reported, with a live birth rate per intended egg retrieval of 58.0% for patients under 35 — among the strongest figures for a high-volume urban academic center in the country. Rates by age group:

For a deeper explanation of how to read these numbers, see our IVF guide.

Patient Experience

A 4.3-star rating for a high-volume academic fertility center at a major New York medical institution is genuinely strong. Patients consistently praise the caliber of the physicians, the organization of the clinical team, and the quality of communication around treatment plans. The center's patient financial coordinators (PFCs) are frequently mentioned as helpful navigators of a complex insurance landscape.

The honest trade-offs are the same ones that accompany any program of this scale. Appointment availability for new patients can lag several weeks, particularly for initial consultations. During active monitoring cycles — when blood draws and ultrasounds happen every two or three days — the Columbus Circle office moves at a pace calibrated to a busy urban practice, not a small boutique clinic. Patients who have trained at smaller independent programs sometimes note a difference in the continuity of care: with multiple physicians covering monitoring days, you may not see your primary REI at every appointment.

These are structural features of academic medicine, not failures of individual physicians. The flip side is that the same volume that creates scheduling friction also produces superior statistical data, greater subspecialty depth, and the ability to handle cases that would exceed the capacity of a two-physician practice. Patients with complex histories, prior failed cycles elsewhere, or medically urgent situations — oncofertility patients especially — often describe Columbia as the most appropriate setting precisely because of its institutional depth. Those seeking maximum intimacy with a single physician may find a boutique practice a better fit for straightforward cases.

Browse other fertility clinics in New York to compare Columbia against independent and single-physician practices across the five boroughs and Long Island.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Financing

New York patients with large-group employer-sponsored health insurance benefit from one of the more significant state fertility mandates in the country. Under New York's 2020 insurance law, fully insured large-group plans (100 or more employees) are required to cover three IVF cycles per covered individual, along with related diagnostic testing. This mandate does not apply to self-funded ERISA plans — which cover many employees of large national companies — so patients must verify their specific plan type before assuming coverage applies.

Columbia University Fertility Center is one of the few IVF programs in New York City that accepts in-network managed care insurance for IVF, which can produce substantial savings compared to out-of-network billing. The center's dedicated PFC team contacts new patients proactively to review coverage and coordinate prior authorizations before a treatment plan is finalized. For patients without IVF insurance coverage, financing options and self-pay estimates are available.

Out-of-pocket IVF costs in New York City typically range from $7,400 to $25,000 per cycle depending on medications, genetic testing, and ancillary services. Patients with active coverage under a qualifying large-group plan may have their primary costs substantially offset by insurance.

Frequently Asked Questions

Is Columbia University Fertility Center really ranked #1 in the United States?

Newsweek ranked Columbia University Fertility Center #1 on its America's Best Fertility Clinics 2025 list. The ranking was based on a nationwide survey of reproductive medicine professionals, SART outcome data, accreditations, and patient satisfaction metrics. The center is also the only fertility clinic in New York City to have received the SART Platinum Award for outstanding outcomes and complete data reporting two consecutive years.

What makes the embryology lab at Columbia different?

The lab is directed by Dr. Eric Forman, who holds the HCLD (High Complexity Laboratory Director) credential and has published landmark research on vitrification and single-embryo transfer. The lab handles more than 4,500 cycles annually, operates its own andrology unit, and is integrated with Columbia's Pre-Pregnancy Genetics Program for in-house PGT. The volume and research oversight distinguish it from labs at lower-volume independent clinics.

Does Columbia offer oncofertility services for urgent cases?

Yes. Dr. Paula Brady's Oncofertility Program specializes in fast-tracking fertility preservation for patients who have just received a cancer diagnosis and need to bank eggs or embryos before beginning chemotherapy, radiation, or surgery. The program coordinates directly with oncology teams at NewYork-Presbyterian and other institutions to minimize delays.

How does Columbia handle LGBTQ+ patients and third-party reproduction?

Dr. Briana Rudick leads the Third Party Reproduction Program, which serves same-sex couples, single parents by choice, and anyone requiring egg donation or gestational surrogacy. The program includes clinical screening of donors, support services for all parties involved, and experience with co-maternity arrangements where both partners participate in the conception process. Columbia does not limit its third-party services by family structure or sexual orientation.